T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 06/30/2015
Volatility and Other Measures
as of 06/30/2015
Beta 0.86
0.30
Standard Deviation 13.09
Price/Earnings Ratio (Domestic) 21.2
Earnings Growth Rate (Domestic) 13.3
Turnover Rate 14.8
Median Market
Capitalization
$39,877.48 Million
10 Largest Holdings
Represents 34.92 % of Total Net Assets
View Holdings as of:
AbbVie
Aetna
Alexion Pharmaceuticals
Allergan
Cigna
Gilead Sciences
Incyte
McKesson
UnitedHealth Group
Valeant Pharmaceuticals International
As of 06/30/2015 the Health Sciences Fund had a total of 164 holdings.
Sector Diversification
as of 06/30/2015
% of Total Net Assets
Biotechnology 31.5%
Services 29.5%
Pharmaceuticals 19.7%
Products & Devices 9.6%
Life Sciences 4.5%
See Glossary for additional details on all data elements.